Laropiprant
Products Laropiprant was included in Tredaptive in combination with nicotinic acid. The drug was approved in many countries in 2009 and was withdrawn from the market in late January 2013 see under Nicotinic Acid. Structure and properties Laropiprant (C21H19ClFNO4S, Mr = 435.9 g/mol) Effects During therapy with the lipid-lowering drug nicotinic acid (niacin), a flush, … Laropiprant
